Although both groups of BD patients presented changes in pro-inflammatory gene expression compared to the control group, only lithium-treated patients showed elevated expression of IL10, the anti-inflammatory cytokine, which may support the lithium immunomodulatory properties in bipolar treatment. Here, IL10 is linked to Behcet disease.